R01 CA115197/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2008	1
2009	3
2010	2
2011	1
2012	1
2013	2
2014	1
2021	0

1

Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Dong X, Mumper RJ. Dong X, et al. Nanomedicine (Lond). 2010 Jun;5(4):597-615. doi: 10.2217/nnm.10.35. Nanomedicine (Lond). 2010. PMID: 20528455 Free PMC article. Review.

2

Oil-filled lipid nanoparticles containing 2'-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancer.

Feng L, Benhabbour SR, Mumper RJ. Feng L, et al. Adv Healthc Mater. 2013 Nov;2(11):1451-7. doi: 10.1002/adhm.201300017. Epub 2013 Apr 19. Adv Healthc Mater. 2013. PMID: 23606545 Free PMC article.

3

Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2'-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles.

Peng L, Feng L, Yuan H, Benhabbour SR, Mumper RJ. Peng L, et al. Nanomedicine. 2014 Oct;10(7):1497-506. doi: 10.1016/j.nano.2014.03.016. Epub 2014 Apr 4. Nanomedicine. 2014. PMID: 24709328 Free PMC article.

4

Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies.

Holpuch AS, Hummel GJ, Tong M, Seghi GA, Pei P, Ma P, Mumper RJ, Mallery SR. Holpuch AS, et al. Pharm Res. 2010 Jul;27(7):1224-36. doi: 10.1007/s11095-010-0121-y. Epub 2010 Mar 31. Pharm Res. 2010. PMID: 20354767 Free PMC article.

5

Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.

Dong X, Mattingly CA, Tseng M, Cho M, Adams VR, Mumper RJ. Dong X, et al. Eur J Pharm Biopharm. 2009 May;72(1):9-17. doi: 10.1016/j.ejpb.2008.11.012. Epub 2008 Dec 10. Eur J Pharm Biopharm. 2009. PMID: 19111929 Free PMC article.

6

Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.

Dong X, Mattingly CA, Tseng MT, Cho MJ, Liu Y, Adams VR, Mumper RJ. Dong X, et al. Cancer Res. 2009 May 1;69(9):3918-26. doi: 10.1158/0008-5472.CAN-08-2747. Epub 2009 Apr 21. Cancer Res. 2009. PMID: 19383919 Free PMC article.

7

Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.

Ma P, Dong X, Swadley CL, Gupte A, Leggas M, Ledebur HC, Mumper RJ. Ma P, et al. J Biomed Nanotechnol. 2009 Apr;5(2):151-61. doi: 10.1166/jbn.2009.1021. J Biomed Nanotechnol. 2009. PMID: 20055093 Free PMC article.

8

Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.

Feng L, Wu H, Ma P, Mumper RJ, Benhabbour SR. Feng L, et al. Int J Nanomedicine. 2011;6:2545-56. doi: 10.2147/IJN.S24954. Epub 2011 Oct 21. Int J Nanomedicine. 2011. PMID: 22072889 Free PMC article.

9

2'-Behenoyl-paclitaxel conjugate containing lipid nanoparticles for the treatment of metastatic breast cancer.

Ma P, Rahima Benhabbour S, Feng L, Mumper RJ. Ma P, et al. Cancer Lett. 2013 Jul 1;334(2):253-62. doi: 10.1016/j.canlet.2012.08.009. Epub 2012 Aug 16. Cancer Lett. 2013. PMID: 22902506 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results